Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gaedigk

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|October 26, 1995
Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivityV J Green, M Pirmohamed, N R Kitteringham, et al.
Pediatric Obesity|September 27, 2018
Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesityV Shakhnovich, S Abdel-Rahman, C A Friesen, et al.
Mutation Research|May 12, 1997
Human acetyltransferase polymorphismsD M Grant, N C Hughes, S A Janezic, et al.
Clinical Pharmacology and Therapeutics|May 14, 2015
Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human LiverK S Burgess, S Philips, E A Benson, et al.
Pharmacogenetics|November 24, 1998
Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotypingA D Kashuba, A N Nafziger, G L Kearns, et al.
Clinical Pharmacology and Therapeutics|December 1, 1999
Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotypingD S Streetman, R E Ellis, A N Nafziger, et al.
The Pharmacogenomics Journal|October 28, 2015
Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohortT M Dodgen, C De J Labuschagne, A van Schalkwyk, et al.
Clinical Pharmacology and Therapeutics|March 30, 2007
Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotypeA Gaedigk, J D Eklund, R E Pearce, et al.
The Pharmacogenomics Journal|July 22, 2017
Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohortT M Dodgen, C De J Labuschagne, A van Schalkwyk, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeK R Crews, A Gaedigk, H M Dunnenberger, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|October 26, 1995
Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivityV J Green, M Pirmohamed, N R Kitteringham, et al.
Pediatric Obesity|September 27, 2018
Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesityV Shakhnovich, S Abdel-Rahman, C A Friesen, et al.
Mutation Research|May 12, 1997
Human acetyltransferase polymorphismsD M Grant, N C Hughes, S A Janezic, et al.
Clinical Pharmacology and Therapeutics|May 14, 2015
Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human LiverK S Burgess, S Philips, E A Benson, et al.
Pharmacogenetics|November 24, 1998
Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotypingA D Kashuba, A N Nafziger, G L Kearns, et al.
Clinical Pharmacology and Therapeutics|December 1, 1999
Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotypingD S Streetman, R E Ellis, A N Nafziger, et al.
The Pharmacogenomics Journal|October 28, 2015
Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohortT M Dodgen, C De J Labuschagne, A van Schalkwyk, et al.
Clinical Pharmacology and Therapeutics|March 30, 2007
Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotypeA Gaedigk, J D Eklund, R E Pearce, et al.
The Pharmacogenomics Journal|July 22, 2017
Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohortT M Dodgen, C De J Labuschagne, A van Schalkwyk, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeK R Crews, A Gaedigk, H M Dunnenberger, et al.
Pageof 5